alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Coffin Syndrome in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morice, E | 1 |
| Farley, S | 1 |
| Poirier, R | 1 |
| Dallerac, G | 1 |
| Chagneau, C | 1 |
| Pannetier, S | 1 |
| Hanauer, A | 1 |
| Davis, S | 1 |
| Vaillend, C | 1 |
| Laroche, S | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Coffin Syndrome
| Article | Year |
|---|---|
Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Coffin-Lowry Syndrome; Conditioni | 2013 |